Añazco Diego, Nicolalde Bryan, Espinosa Isabel, Camacho Jose, Mushtaq Mariam, Gimenez Jimena, Teran Enrique
Colegio de Ciencias de la Salud, Universidad San Francisco de Quito, Quito, Ecuador.
Colegio de Ciencias e Ingenieria, Universidad San Francisco de Quito, Quito, Ecuador.
PeerJ. 2021 Mar 3;9:e10927. doi: 10.7717/peerj.10927. eCollection 2021.
Preprints are preliminary reports that have not been peer-reviewed. In December 2019, a novel coronavirus appeared in China, and since then, scientific production, including preprints, has drastically increased. In this study, we intend to evaluate how often preprints about COVID-19 were published in scholarly journals and cited.
We searched the iSearch COVID-19 portfolio to identify all preprints related to COVID-19 posted on bioRxiv, medRxiv, and Research Square from January 1, 2020, to May 31, 2020. We used a custom-designed program to obtain metadata using the Crossref public API. After that, we determined the publication rate and made comparisons based on citation counts using non-parametric methods. Also, we compared the publication rate, citation counts, and time interval from posting on a preprint server to publication in a scholarly journal among the three different preprint servers.
Our sample included 5,061 preprints, out of which 288 were published in scholarly journals and 4,773 remained unpublished (publication rate of 5.7%). We found that articles published in scholarly journals had a significantly higher total citation count than unpublished preprints within our sample ( < 0.001), and that preprints that were eventually published had a higher citation count as preprints when compared to unpublished preprints ( < 0.001). As well, we found that published preprints had a significantly higher citation count after publication in a scholarly journal compared to as a preprint ( < 0.001). Our results also show that medRxiv had the highest publication rate, while bioRxiv had the highest citation count and shortest time interval from posting on a preprint server to publication in a scholarly journal.
We found a remarkably low publication rate for preprints within our sample, despite accelerated time to publication by multiple scholarly journals. These findings could be partially attributed to the unprecedented surge in scientific production observed during the COVID-19 pandemic, which might saturate reviewing and editing processes in scholarly journals. However, our findings show that preprints had a significantly lower scientific impact, which might suggest that some preprints have lower quality and will not be able to endure peer-reviewing processes to be published in a peer-reviewed journal.
预印本是未经同行评审的初步报告。2019年12月,一种新型冠状病毒在中国出现,从那时起,包括预印本在内的科研成果产出急剧增加。在本研究中,我们旨在评估关于新型冠状病毒肺炎(COVID-19)的预印本在学术期刊上发表及被引用的频率。
我们检索了iSearch COVID-19资料库,以识别2020年1月1日至2020年5月31日期间在bioRxiv、medRxiv和Research Square上发布的所有与COVID-19相关的预印本。我们使用一个定制程序通过CrossRef公共应用程序编程接口获取元数据。之后,我们确定发表率,并使用非参数方法基于引用次数进行比较。此外,我们比较了三个不同预印本服务器上的发表率、引用次数以及从在预印本服务器上发布到在学术期刊上发表的时间间隔。
我们的样本包括5061篇预印本,其中288篇在学术期刊上发表,4773篇未发表(发表率为5.7%)。我们发现,在我们的样本中,在学术期刊上发表的文章的总引用次数显著高于未发表的预印本(<0.001),并且最终发表的预印本与未发表的预印本相比,作为预印本时引用次数更高(<0.001)。同样,我们发现已发表的预印本在学术期刊上发表后的引用次数显著高于作为预印本时的引用次数(<0.001)。我们的结果还表明,medRxiv的发表率最高,而bioRxiv的引用次数最高,且从在预印本服务器上发布到在学术期刊上发表的时间间隔最短。
尽管多个学术期刊加快了发表速度,但我们发现样本中的预印本发表率极低。这些发现可能部分归因于COVID-19大流行期间观察到的科研成果产出前所未有的激增,这可能使学术期刊的评审和编辑流程饱和。然而,我们的研究结果表明,预印本的科学影响力显著较低,这可能表明一些预印本质量较低,无法经受同行评审流程而在同行评审期刊上发表。